Status:
COMPLETED
Comparing Single-dose Low-volume PEG Plus Bisacodyl vs. Split-dose PEG for Bowel Preparation in Morning Colonoscopy
Lead Sponsor:
Taipei Medical University WanFang Hospital
Conditions:
Bowel Preparation
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Colonoscopy is the best method to detect colorectal cancer and colonic polyps. Studies showed that adenoma detection rate positive correlation with good bowel preparation which makes bowel preparation...
Detailed Description
Colorectal cancer incidence rate has increased in recently years, and colorectal cancer has come to the top of cancer incidence ranking of Taiwan. Colonoscopy is the best method to detect colorectal c...
Eligibility Criteria
Inclusion
- Age between 20-70 years.
- Out-patient department ambulatory patient.
- Patients who have indications to receive colonoscopy.
Exclusion
- Age is under 20 or over 70
- Have severe renal impairment (hemodialysis or eGFR\<30).
- Have severe congestive heart failure (NYHAⅢorⅣ).
- Pregnant or lactating, or women is under oral contraceptive.
- Have history of bowel obstruction or resection, known or suspected gastroparesis acute gastric/intestinal ulcer, toxic colitis or megacolon
- Be allergic to polyethylene glycol (PEG) or bisacodyl.
- Have severe constipation ( ≤ 1 bowel movement per week).
- Patient who has Phenylketonuria.
- Refuse to sign consent to the study.
Key Trial Info
Start Date :
July 14 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT03248726
Start Date
July 14 2017
End Date
September 30 2019
Last Update
October 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wanfang Hospital
Taipei, Taiwan, 116